The GLP is committed to full transparency. Download and review our Annual Report.

Bayer lawsuit: Here’s how plaintiffs in next Roundup trial will try to show glyphosate causes cancer

| | March 18, 2019

A late March start date is scheduled for a California state court trial of plaintiffs, Alva and Alberta Pilliod, against Monsanto/Bayer claiming nearly 26 years of Roundup use on four properties caused each to incur different sub-types of Non-Hodgkin’s Lymphoma (NHL).

[The] Oakland state court trial is not bifurcated into causation and liability phases as the Hardeman federal court trial and will be similar to [the August 2018 Johnson trial against Bayer] which was tried in San Francisco state court. Again, as with the Johnson trial, there will be an inordinate amount of trial time devoted to parsing and interpretation of Monsanto historical documents.

Related article:  How European-Based NGOs Block Crop Biotechnology Adoption In Africa

[The Plaintiff’s] specific causation medical experts will attempt to infer from epidemiological studies and assign NHL cancer responsibility to Roundup in spite of other causative factors and defense’s medical experts will do the opposite….

Predictably, closing arguments will mirror the Johnson trial closings because of the intermixing of causation and document interpretation allegations. Again, as with Johnson, the jury verdict will largely depend on [the] degree of influence for alleged corporate wrongdoing, judicial flexibility with respect to epidemiological inferences and the other, as yet undefined, causal medical factors.

Read full, original article: Preview of Pilliods v. MonsantoTrial: Late March 2019

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend